182 related articles for article (PubMed ID: 29943228)
1. [S1 guidelines on malignant hyperthermia : Update 2018].
Wappler F
Anaesthesist; 2018 Jul; 67(7):529-532. PubMed ID: 29943228
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
3. Donating Dantrolene: Development and Implementation of a Malignant Hyperthermia Program in a Scarce Resource Setting.
Smith A; Brandom B; Miner L; Henker R
AANA J; 2022 Aug; 90(4):271-277. PubMed ID: 35943752
[TBL] [Abstract][Full Text] [Related]
4. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
[TBL] [Abstract][Full Text] [Related]
5. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
[TBL] [Abstract][Full Text] [Related]
6. Dantrolene in porcine malignant hyperthermia.
Gronert GA; Milde JH; Theye RA
Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
[TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
8. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia with excellent response to small dose of dantrolene.
Chang KY; Ting CK; Chan KH; Tsai SK
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
[TBL] [Abstract][Full Text] [Related]
10. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
Alitalo I; Schulman A
Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
[TBL] [Abstract][Full Text] [Related]
11. Do we foresee new emerging drugs to treat malignant hyperthermia?
Just KS; Gerbershagen MU; Grensemann J; Wappler F
Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
[TBL] [Abstract][Full Text] [Related]
12. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Friesen CM; Brodsky JB; Dillingham MF
Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
[TBL] [Abstract][Full Text] [Related]
13. Postoperative malignant hyperthermia and dantrolene therapy.
Schulte-Sasse U; Hess W; Eberlein HJ
Can Anaesth Soc J; 1983 Nov; 30(6):635-40. PubMed ID: 6640400
[TBL] [Abstract][Full Text] [Related]
14. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
Hall GM; Lucke JN; Orchard C; Lovell R; Lister D
Anaesthesia; 1982 Dec; 37(12):1167-70. PubMed ID: 7181063
[TBL] [Abstract][Full Text] [Related]
15. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
Harrison GG
S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
[TBL] [Abstract][Full Text] [Related]
16. [Malignant hyperthermia in swine during isoflurane anesthesia].
Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
18. Dantrolene in malignant hyperthermia (MH)-susceptible patients with exaggerated exercise stress.
Gronert GA
Anesthesiology; 2000 Sep; 93(3):905. PubMed ID: 10969335
[No Abstract] [Full Text] [Related]
19. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
